GLP-1 receptor agonists e.g., semaglutide, liraglutide commonly cause gastrointestinal adverse effects such as nausea, vomiting, diarrhea, constipation, and abdominal discomfort, especially during dose escalation, less common risks include pancreatitis, gallbladder disease, and hypoglycemia mainly with insulin sulfonylureas
Contact us today for more information about Semaglutide GLP-1 injections or to book an appointment were happy to get started as soon as you are
Both surgery and GLP-1s are part of a continuum of treatments for obesity
GLP-1 receptor agonists work to decrease your appetite and help you feel fuller sooner, says UCLA Health clinical nutrition expert Dr
Can Oral GLP-1 Therapies Overtake Injectables